A Mobile and Virtual Reality Intervention for Adolescent Depression
Evaluating the Feasibility of Limbix Spark: a Cognitive Behavioral Therapy Based Mobile and Virtual Reality Intervention for Adolescent Depression
1 other identifier
interventional
30
1 country
1
Brief Summary
Depression, the most common mental health disorder among adolescents, is a critical health problem within the US. In this study, the feasibility, acceptability, and preliminary efficacy of Limbix Spark, a cognitive behavioral therapy (CBT)- based mobile app + virtual reality (VR) program for helping adolescents live well with depression will be investigated. This program is specifically designed around behavioral activation theory, the idea that completing activities that make a patient feel pleasure or provide a sense of mastery are effective in reducing symptoms of depression. The program involves the use of both VR and a mobile app that include CBT components like psychological assessments, psychoeducation, and skills training. 30 participants aged 12-21 years old with mild to severe depressive symptoms and smartphone access will be enrolled in this study. The primary efficacy outcome measures will be depressive symptoms with anxiety symptoms, functional outcomes, and dimensional scales of positive and negative affect and behavioral activation serving as secondary outcome measures. Qualitative and quantitative feedback on the use of the VR + mobile app (ease of use, comfort, willingness to use again) will be assessed using questionnaires. Engagement and adherence to the program will be assessed by assessing VR and app usage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable depression
Started Oct 2019
Shorter than P25 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 12, 2019
CompletedFirst Submitted
Initial submission to the registry
November 11, 2019
CompletedFirst Posted
Study publicly available on registry
November 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 19, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 17, 2020
CompletedJuly 7, 2020
July 1, 2020
5 months
November 11, 2019
July 6, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Adherence to program
% of enrolled participants completing all sessions at post treatment
Post treatment (5 weeks)
Change in depression post treatment
Change in depressive symptoms measured by Personal Health Questionnaire (PHQ-8) (min: 0; max: 24, with higher score indicating more severe depression).
Change from Baseline to Post treatment (5 weeks)
Secondary Outcomes (1)
Change in depression at one month follow up
Change from Baseline to 1 month follow up (9 weeks)
Study Arms (1)
Limbix Spark
EXPERIMENTALA 5 week mobile + virtual reality CBT-based program
Interventions
5-week, self-guided mobile + VR CBT-based program for adolescent depression
Eligibility Criteria
You may qualify if:
- Score of 10 or greater on Patient Health Questionnaire (PHQ-8)
- English fluency and literacy
- Access to a smart phone
- Patient willing to provide informed consent/assent and have parent/guardian willing to provide informed consent if under 18.
You may not qualify if:
- Seizure disorder or other neurological disorder
- Prior diagnosis of or receiving treatment for substance use disorder, bipolar disorder, or psychosis
- Significant vision or hearing impairment
- Hospitalized or received residential/inpatient treatment for a suicide attempt or self-harming behaviors within the past 3 months
- Current diagnosis of a reading/learning or intellectual disability.
- Receiving treatment (including but not limited to medication or psychotherapy) for a cognitive disorder, including attention deficit hyperactivity disorder (ADHD).
- Are currently participating in a treatment study.
- Pregnancy
- History of significant motion sickness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Limbix Health, Inc.
Los Angeles, California, 90266-2558, United States
Related Publications (1)
Miller I, Peake E, Strauss G, Vierra E, Koepsell X, Shalchi B, Padmanabhan A, Lake J. Self-Guided Digital Intervention for Depression in Adolescents: Feasibility and Preliminary Efficacy Study. JMIR Form Res. 2023 Nov 22;7:e43260. doi: 10.2196/43260.
PMID: 37991839DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jessica Lake, PhD
Director of Research
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 11, 2019
First Posted
November 18, 2019
Study Start
October 12, 2019
Primary Completion
March 19, 2020
Study Completion
April 17, 2020
Last Updated
July 7, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share